<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A37C26E5-E9ED-4B87-B088-37DFDC5231BC"><gtr:id>A37C26E5-E9ED-4B87-B088-37DFDC5231BC</gtr:id><gtr:firstName>Carl</gtr:firstName><gtr:surname>Counsell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5AC23B43-6F21-41CC-ACCD-BECFEE1B6C61"><gtr:id>5AC23B43-6F21-41CC-ACCD-BECFEE1B6C61</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:surname>Linington</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8E480CF4-8B66-46FE-BC8B-61F63BF0528A"><gtr:id>8E480CF4-8B66-46FE-BC8B-61F63BF0528A</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Vickers</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D39EAFBE-B12E-41F5-AEBA-3DC00BE5113F"><gtr:id>D39EAFBE-B12E-41F5-AEBA-3DC00BE5113F</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>N.</gtr:otherNames><gtr:surname>Barker</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0401603"><gtr:id>1F96D5DD-6597-44A6-A272-2A3A8B47FBB5</gtr:id><gtr:title>Aberrant T regulatory cell responses to candidate viral and auto-antigens in the pathogenesis of multiple sclerosis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0401603</gtr:grantReference><gtr:abstractText>Multiple sclerosis (MS) affects over 80,000 people in the UK and may cause paralysis, blindness and problems with sensation. It is a disease that seems to be caused by attacks of the immune system on parts of the brain. Many researchers think it may be caused by an unusual response to an infection, as it occurs in clusters, especially in colder climates. The leading candidate infectious agent is Epstein-Barr virus, the cause of glandular fever, which has infected almost all patients with MS. After initial infection, the virus lives on in people as a latent form. We have shown that latent EBV fools the immune system into thinking it is not a problem by stimulating a special sort of immune cell called a regulatory T cell. Knowing that the immune response to EBV may be important in MS, we recently looked at the regulatory T cell response to EBV in patients with MS and found that it was strikingly different to that of healthy people. We now propose to look at these differences in more detail to establish the way in which infection with such a virus might lead to the disease.</gtr:abstractText><gtr:technicalSummary>Several epidemiological features of multiple sclerosis (MS), especially geographical and temporal clustering, have suggested the importance of exposure to an infectious agent during childhood or adolescence in its pathogenesis. The best of these associations is with Epstein-Barr virus (EBV). A meta-analysis of case control studies, as well as subsequent data, has shown that over 99% of patients with MS have been infected, with a summary odds ratio of over 13 compared to controls. Other case-control studies have shown that infectious mononucleosis and high anti-EBV antibody titres are risk factors for the subsequent development of MS. If EBV is causal, it would be predicted that the immune response to latent infection is pathological. We have previously shown that the immune responses to at least two EBV latent antigens are dominated by regulatory T cells. Furthermore, we now have pilot data showing that the regulatory T cell response to EBV latent and antigens differ substantially from healthy donors. We therefore propose to study regulatory immune responses to an EBV latent antigen (LMP1) and an auto-antigen (MOG) in cross-sectional and longitudinal case control studies of patients with MS. We will also study these responses in healthy subjects before and after EBV infection, apparently EBV seronegative MS patients and monozygotic twin pairs both concordant and discordant for MS. In this way, we will test the hypotheses that either EBV infection is an important factor in the immunopathogenesis of MS or the aberrant immune responses we have observed and MS share common causation.</gtr:technicalSummary><gtr:fund><gtr:end>2009-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>250158</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Multiple Sclerosis Research</gtr:department><gtr:description>The effects of vitamin D or UV light on Treg function in patients with MS</gtr:description><gtr:id>B396265E-8086-4CBA-BAD2-E880594EC9B9</gtr:id><gtr:impact>Grant Application to Chief Scientist's Office submitted but now rejected
Project completed and paper written &amp;quot;The effect of ultraviolet light on systemic immune function and 25-hydroxyvitamin D&amp;quot;. About to be submitted to Journal of Allergy and Clinical Immunology. After submission, we will apply again to the Chief Scientist's Office.</gtr:impact><gtr:outcomeId>dU5HFeNuLGX-2</gtr:outcomeId><gtr:partnerContribution>Development of clinical trial protocolDevelopment of protocol to test Treg function</gtr:partnerContribution><gtr:piContribution>I instigated a partnership between several internal collaborators (specialists in clinical trials, UV phototherapy)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Section of Ageing &amp; Health</gtr:department><gtr:description>The effects of vitamin D or UV light on Treg function in patients with MS</gtr:description><gtr:id>5C56325D-05FD-436B-BFC7-925CE26D933C</gtr:id><gtr:impact>Grant Application to Chief Scientist's Office submitted but now rejected
Project completed and paper written &amp;quot;The effect of ultraviolet light on systemic immune function and 25-hydroxyvitamin D&amp;quot;. About to be submitted to Journal of Allergy and Clinical Immunology. After submission, we will apply again to the Chief Scientist's Office.</gtr:impact><gtr:outcomeId>dU5HFeNuLGX-1</gtr:outcomeId><gtr:partnerContribution>Development of clinical trial protocolDevelopment of protocol to test Treg function</gtr:partnerContribution><gtr:piContribution>I instigated a partnership between several internal collaborators (specialists in clinical trials, UV phototherapy)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Applied Health Sciences</gtr:department><gtr:description>EBV meta-analyses</gtr:description><gtr:id>45A90B0E-A850-43BE-8E72-76C33A6ABE87</gtr:id><gtr:impact>Almohmeed YH, Avenell A, Aucott L, Vickers MA. Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and Multiple Sclerosis. PLoS One. 2013 Apr 9;8(4):e61110. doi: 10.1371/journal.pone.0061110. Print 2013.

Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus.
Hanlon P, Avenell A, Aucott L, Vickers MA.
Arthritis Res Ther. 2014 Jan 6;16(1):R3. doi: 10.1186/ar4429.

BMC Infect Dis. 2014 Mar 20;14:151. doi: 10.1186/1471-2334-14-151.
The epidemiology of infectious mononucleosis in Northern Scotland: a decreasing incidence and winter peak.
Visser E1, Milne D, Collacott I, McLernon D, Counsell C, Vickers M.</gtr:impact><gtr:outcomeId>KpmdjRJiXUM-1</gtr:outcomeId><gtr:partnerContribution>Jointly performed meta-analyses</gtr:partnerContribution><gtr:piContribution>Jointly performed meta-analyses</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Poster session Stuart Centre</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>B0652ACE-F5BE-4536-97FB-6919EE7C77EA</gtr:id><gtr:impact>Prepared and manned a poster at a patient/relative open day

Patients seeemed interested but difficult to quantify impact</gtr:impact><gtr:outcomeId>1327F77766F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture Stuart Centre</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>1162CD34-03B5-4D92-8327-037762114B27</gtr:id><gtr:impact>Lecture to MS group

None quantifiable</gtr:impact><gtr:outcomeId>D150E3DB713</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview on BBC Scotland news</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>38038DAE-C42E-43B2-8768-3B1F1822C920</gtr:id><gtr:impact>Interviewed about vitamin D on BBC Scotland 6pm news

Difficult to quantify.</gtr:impact><gtr:outcomeId>9BC28F5A073</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Session on Radio Scotland</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>F4211873-0264-4F42-A8A0-5D56EB7985F2</gtr:id><gtr:impact>Took part in phone-in on vitamin D

Difficult to quantify impact on listening audience.</gtr:impact><gtr:outcomeId>AA87E6D2558</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with Herald newspaper</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>78638CF5-F99B-4DBA-8CCC-F8B2E8AD3B55</gtr:id><gtr:impact>Was interviewed by reporter from 'The Herald' concerning MS, particularly its links with vitamin D deficiency

Difficult to quantify.</gtr:impact><gtr:outcomeId>3A8E603083D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit, Aberdeen</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>6436964D-3D69-4F26-8655-0E0FE64F950A</gtr:id><gtr:impact>Gave talk and asked questions on MS

Pupils seemed interested and asked numerous questions. Difficult to quantify impact.</gtr:impact><gtr:outcomeId>268AB5FD7E8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Stored plasma/serum samples of patients with MS.
Database of patients with MS now being developed into full survey. This database being used to collect genetic samples.</gtr:description><gtr:id>2C85B081-16E8-4164-AF6C-3EEF4EB65ACE</gtr:id><gtr:impact>Database being used to collect DNA samples for genetic studies in Cambridge and Edinburgh</gtr:impact><gtr:outcomeId>f81ZChMofQB</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MS serum bank</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">G0401603</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>